Contact
searchSearch
HMP Global

Conference Coverage

Farris
Conference Coverage
Evidence for Longevity-Focused Nutraceuticals Remains Mixed Despite Growing Consumer Demand
05/16/2026
Jessica Garlewicz
Interest in nutraceuticals targeting healthspan and longevity continues to expand, but clinical evidence supporting many commonly promoted compounds remains inconsistent.
Interest in nutraceuticals targeting healthspan and longevity continues to expand, but clinical evidence supporting many commonly promoted compounds remains inconsistent.
Interest in nutraceuticals...
05/16/2026
The Dermatologist
Doris Day
Conference Coverage
Filler Use Shifts Toward Structural Preservation and Long-Term Aesthetic Planning
05/16/2026
Jessica Garlewicz
Concerns about “filler fatigue” are reshaping aesthetic dermatology, but demand for fillers remains strong when treatments prioritize natural movement, structural balance, and long-term facial preservation.
Concerns about “filler fatigue” are reshaping aesthetic dermatology, but demand for fillers remains strong when treatments prioritize natural movement, structural balance, and long-term facial preservation.
Concerns about “filler fatigue”...
05/16/2026
The Dermatologist
Rieder
Conference Coverage
Psychiatric Awareness and Boundary Setting Remain Essential in Cosmetic Dermatology
05/16/2026
Jessica Garlewicz
Psychiatric comorbidities and challenging patient dynamics are increasingly relevant in cosmetic dermatology, requiring clinicians to develop practical communication strategies, clear boundaries, and awareness of mental health concerns.
Psychiatric comorbidities and challenging patient dynamics are increasingly relevant in cosmetic dermatology, requiring clinicians to develop practical communication strategies, clear boundaries, and awareness of mental health concerns.
Psychiatric comorbidities and...
05/16/2026
The Dermatologist
Tanzi
Conference Coverage
Fractional Lasers and PDL May Reduce Future Keratinocyte Carcinoma Risk
05/16/2026
Jessica Garlewicz
Emerging evidence suggests that certain laser and resurfacing procedures may reduce the future risk of nonmelanoma skin cancerwhile simultaneously improving photodamaged skin.
Emerging evidence suggests that certain laser and resurfacing procedures may reduce the future risk of nonmelanoma skin cancerwhile simultaneously improving photodamaged skin.
Emerging evidence suggests that...
05/16/2026
The Dermatologist
Bertucci
Conference Coverage
“NoseTox” Techniques Emphasize Muscle Dynamics and Precision Injection
05/16/2026
Jessica Garlewicz
Understanding nasal muscle interactions may improve aesthetic outcomes with neuromodulator treatments targeting the lower face and nose.
Understanding nasal muscle interactions may improve aesthetic outcomes with neuromodulator treatments targeting the lower face and nose.
Understanding nasal muscle...
05/16/2026
The Dermatologist
Thor
Conference Coverage
Obesity and Aging Share Biological Pathways Linked to Longevity Risk
05/16/2026
Jessica Garlewicz
Obesity and aging may be biologically interconnected processes that contribute to accelerated functional decline and increased mortality risk.
Obesity and aging may be biologically interconnected processes that contribute to accelerated functional decline and increased mortality risk.
Obesity and aging may be...
05/16/2026
The Dermatologist
Conference Coverage
Microneedling Radiofrequency Evolves as a Versatile Option for Skin Remodeling
05/16/2026
Jessica Garlewicz
Microneedling with radiofrequency continues to expand within procedural dermatology, offering a non-chromophore-dependent approach to skin remodeling and scar treatment.
Microneedling with radiofrequency continues to expand within procedural dermatology, offering a non-chromophore-dependent approach to skin remodeling and scar treatment.
Microneedling with...
05/16/2026
The Dermatologist
E. Victor Ross, MD
Conference Coverage
Objective Skin Color Measurement May Improve Laser Safety and Treatment Precision
05/15/2026
Jessica Garlewicz
Objective assessment of skin pigmentation may improve parameter selection and reduce complications in visible light–based dermatologic procedures.
Objective assessment of skin pigmentation may improve parameter selection and reduce complications in visible light–based dermatologic procedures.
Objective assessment of skin...
05/15/2026
The Dermatologist
solish
Conference Coverage
Secretomes in Dermatology: Expanding Regenerative Approaches Beyond PRP
05/15/2026
Jessica Garlewicz
Secretome-based therapies may represent an emerging direction in regenerative dermatology, offering a broad range of bioactive molecules that support tissue repair, skin rejuvenation, and hair growth.
Secretome-based therapies may represent an emerging direction in regenerative dermatology, offering a broad range of bioactive molecules that support tissue repair, skin rejuvenation, and hair growth.
Secretome-based therapies may...
05/15/2026
The Dermatologist
Sarah Allen
Conference Coverage
Combination Biostimulation Strategy Aims to Improve Body Contouring Efficiency
05/15/2026
Jessica Garlewicz
This session addressed persistent limitations in nonsurgical body contouring, particularly the large volume of injectable product often required to achieve visible results.
This session addressed persistent limitations in nonsurgical body contouring, particularly the large volume of injectable product often required to achieve visible results.
This session addressed...
05/15/2026
The Dermatologist

Popular Articles

Case Report
Stage II Hodgkin Lymphoma and Bleomycin-Induced Flagellate Rash
06/06/2024
Danielle Randolph; Sandra Marchese Johnson, MD, FAAD; Katharin Janda, MD
New onset of pruritus and weight loss in a healthy young person should prompt an investigation for underlying causes of itch.
New onset of pruritus and weight loss in a healthy young person should prompt an investigation for underlying causes of itch.
New onset of pruritus and weight...
06/06/2024
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.15% for Treatment of Atopic Dermatitis in Adults and Children Aged 6 and Older
07/09/2024
Riya Gandhi, MA
The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.
The US Food and Drug Administration has approved roflumilast cream 0.15% for the treatment of mild to moderate atopic dermatitis in adults and children aged 6 and older.
The US Food and Drug...
07/09/2024
The Dermatologist
Surgical Pearls
Optimizing Dermatologic Surgery Care
09/06/2024
Riya Gandhi, MA
Gain valuable insights to enhance patient outcomes and stay informed about the evolving landscape of dermatologic surgery.
Gain valuable insights to enhance patient outcomes and stay informed about the evolving landscape of dermatologic surgery.
Gain valuable insights to...
09/06/2024
The Dermatologist
rosacea
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
Riya Gandhi, MA
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
AD
News
Efficacy of Targeted Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: A Network Meta-Analysis
06/15/2024
Riya Gandhi, MA
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in...
06/15/2024
The Dermatologist
April/May 2026 cover

Current Issue

May 2026
Volume 34
Issue 3
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist
psoriasis
Quiz
Quiz: Misdiagnosis of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized pustular psoriasis is often misdiagnosed?
What is the reason generalized...
03/02/2026
The Dermatologist
Quiz
Allergic Disease Progression: Genetics and Environment
02/26/2026
Riya Gandhi, MA
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between allergic disease trends, genetic timelines, and the clinical framework used to describe the progression of atopic conditions across childhood.
Explore the relationship between...
02/26/2026
The Dermatologist
Quiz
Early Intervention Strategies in Pediatric Atopic Dermatitis
02/26/2026
Riya Gandhi, MA
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of early skin barrier interventions in infants and the clinical rationale for prompt treatment of atopic dermatitis in young children, including implications for long-term disease outcomes.
Assess your understanding of...
02/26/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use